Zafgen's Series C Round

Zafgen raised a round of funding on July 07, 2011. Investors include Third Rock Ventures.

Zafgen is a biopharmaceutical company dedicated to significantly improving the health and well-being of patients affected by obesity. Beloranib, Zafgen's lead product candidate, is a novel, first-in-c…

Articles about Zafgen's Series C Round: